NASDAQ: OBIO
Orchestra Biomed Holdings Inc Earnings Dates, Reports, Calls

Orchestra Biomed Holdings earnings were -$54.9M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest OBIO earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$20.7M, down 444.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, OBIO reported annual earnings of -$53.0M, with -13.2% growth. The next OBIO earnings date is Aug 6, 2026.

OBIO earnings history

Current Revenue
$32.7M
Current Earnings
-$54.9M
Current Profit Margin
-167.6%

OBIO Return on Equity

Current Company
-158.1%
Current Industry
-142%
Current Market
13.5%
OBIO's Return on Equity (-158.1%)... subscribe to Premium to read more.
High Return on Equity Performance

OBIO Return on Assets

Current Company
-60.4%
Current Industry
-13.7%
OBIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when OBIO announces earnings.

OBIO Return on Capital Employed

Current Company
-60.37%
Current Industry
-9.5%
OBIO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OBIO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OBIO-$51.55M-$54.86MN/A-$0.97
FHTX-$69.26M-$75.32MN/A-$1.16
EDIT-$106.88M-$108.95MN/A-$1.17
AKBA$2.45M-$20.51MN/A-$0.08
TRDA-$161.20M-$166.12MN/A-$3.99

OBIO earnings dates

Next earnings date
Aug 6, 2026

Orchestra Biomed Holdings Earnings Reports & History FAQ

What were Orchestra Biomed Holdings's earnings last quarter?

Orchestra Biomed Holdings (NASDAQ: OBIO) reported Q1 2026 earnings per share (EPS) of -$0.33, up 32.65% year over year. Total OBIO earnings for the quarter were -$20.66 million. In the same quarter last year, Orchestra Biomed Holdings's earnings per share (EPS) was -$0.49.

If you're new to stock investing, here's how to buy Orchestra Biomed Holdings stock.

When does Orchestra Biomed Holdings report earnings?

The next OBIO earnings call is Invalid Date. Add OBIO to your watchlist to be reminded of Orchestra Biomed Holdings's next earnings date.

Is Orchestra Biomed Holdings profitable or losing money?

As of the last Orchestra Biomed Holdings earnings report, Orchestra Biomed Holdings is currently losing money. Orchestra Biomed Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$54.64 million, a 17.61% decrease year over year.

What was OBIO's earnings growth in the past year?

As of Orchestra Biomed Holdings's earnings date in Q2 2026, Orchestra Biomed Holdings's earnings has grown year over year. OBIO earnings in the past year totalled -$54.86 million.

What are Orchestra Biomed Holdings's earnings expectations?

The current EPS estimate for Orchestra Biomed Holdings's earnings report in Invalid Date is -$0.39.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.